Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
800 results
- “Answers in Hours” A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures: Complete Statistical AnalysisIndependent statistical analysis of "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 12- Week Open Label Treatment of Refractory Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of 12- Week Open Label Treatment of Refractory Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223496).
- 2 Dose Neuraxial Morphine for Prevention of PDPH: Complete Statistical AnalysisIndependent statistical analysis of 2 Dose Neuraxial Morphine for Prevention of PDPH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02473276).
- 276Independent statistical analysis of A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 337Independent statistical analysis of BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: Complete Statistical AnalysisIndependent statistical analysis of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00450242).
- 68 Ga-PSMA for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of 68 Ga-PSMA for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04614363).
- 68Ga PSMA in Preprostatectomy Patients: Complete Statistical AnalysisIndependent statistical analysis of 68Ga PSMA in Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388346).
- 6MPIndependent statistical analysis of A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients: Complete Statistical AnalysisIndependent statistical analysis of 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: Complete Statistical AnalysisIndependent statistical analysis of A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB): Complete Statistical AnalysisIndependent statistical analysis of A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near Vision in Presbyopic Patients: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near Vision in Presbyopic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831544).
- A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration: primary endpoint results,…
- A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN): Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants: primary endpoint results, effect estimate…
- A First Human Study of a Ferroportin Antibody: Complete Statistical AnalysisIndependent statistical analysis of A First Human Study of a Ferroportin Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330953).
- A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH): Complete Statistical AnalysisIndependent statistical analysis of A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02651675).
- A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su)…
- A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145): Complete Statistical AnalysisIndependent statistical analysis of A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors: Complete Statistical AnalysisIndependent statistical analysis of A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy: Complete Statistical AnalysisIndependent statistical analysis of A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer: Complete Statistical AnalysisIndependent statistical analysis of A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate…
- A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma: primary endpoint results, effect estimate with confidence…
- A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05053035).
- A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma: primary endpoint results, effect estimate with confidence interval,…
- A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy: primary endpoint…
- A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003): Complete Statistical AnalysisIndependent statistical analysis of A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003): primary endpoint results, effect estimate with confidence…
- A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…